Autres langues Seer, Inc.

Actions

SEER

US81578P1066

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
1,995 ^USD	-3,16 %		-10,94 %	+2,84 %

08/05	Transcript : Seer, Inc., Q1 2024 Earnings Call, May 08, 2024
08/05	Seer, Inc. (NasdaqGS:SEER) annonce un rachat d'actions pour une valeur de 25 millions de dollars.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Earnings Flash (SEER) SEER Posts Q1 Revenue $3.1M, vs. Street Est of $3.8M	08/05
Seer, Inc. announces an Equity Buyback for $25 million worth of its shares.	08/05
Seer Reports First Quarter 2024 Financial Results	08/05
Seer, Inc. Provides Revenue Guidance for the Full Year 2024	08/05
Seer, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions	08/05
Seer, Inc. Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions	08/05
Seer, Inc. authorizes a Buyback Plan.	03/05
Seer to Report First Quarter 2024 Financial Results on May 8, 2024	23/04
Seer, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29/02
Seer, Inc. Provides Revenue Guidance for the Full Year 2024	29/02
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook	29/02
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook	29/02
Earnings Flash (SEER) SEER Reports Q4 Revenue $4.4M, vs. Street Est of $4.05M	29/02
Seer to Participate in the TD Cowen 44th Annual Health Care Conference	21/02
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery	06/02
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery	06/02
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024	01/02
Seer, Inc. Announces Board and Committee Changes	22/12
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference	21/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Seer, Inc.

Actions

SEER

US81578P1066

Autres langues

Filtres